Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK)
Lung cancer is a tumor pathology that includes a group of neoplasms with different biological characteristics, which determine the course of the disease and the potential treatment response depending on the subtype diagnosed. Non-small lung carcinoma corresponds to 85 % of all lung cancers. Adenocar...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
International Association of Physical Chemists (IAPC),
2017-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |